ABSTRACT:
The aqueous leaves extract of Tridax procumbent (Linn) was evaluated for its antidiabetic potential on normal and streptozotocin (STZ)-induced diabetic rats. In the chronic model, the hydromethanolic leaf extract was administered to normal and STZ- induced diabetic rats at the doses of 200 and 400mg/kg body weight (b.w.) p.o. per day for 14 days. The fasting Blood Glucose Levels (BGL), serum insulin level and biochemical data such as glycosylated hemoglobin, Total Cholesterol (TC), Triglycerides (TG), High Density Lipoproteins (HDL) and Low Density Lipoproteins (LDL) were evaluated and all were compared to that of the known anti-diabetic drug glibenclamide. The statistical data indicated significant increase in the body weight, liver glycogen, serum insulin and HDL levels and decrease in blood glucose, glycosylated hemoglobin, total cholesterol and serum triglycerides when compared with glibenclamide. Thus the hydromethanolic leaves extract of Tridax procumben had beneficial effects in reducing the elevated blood glucose level and lipid profile of STZ-induced diabetic rats.
Cite this article:
Raman Chandak, Harshada Tayade. Evaluation of Antidibetic Potential of Hydromethanolic Extract of Tridax procubens (Linn) in Mice. Research Journal of Pharmacology and Pharmacodynamics 2023;15(1):1-5. doi: 10.52711/2321-5836.2023.00001
Cite(Electronic):
Raman Chandak, Harshada Tayade. Evaluation of Antidibetic Potential of Hydromethanolic Extract of Tridax procubens (Linn) in Mice. Research Journal of Pharmacology and Pharmacodynamics 2023;15(1):1-5. doi: 10.52711/2321-5836.2023.00001 Available on: https://rjppd.org/AbstractView.aspx?PID=2023-15-1-1
REFERENCES:
1. C. O. Eleazu, K. C. Eleazu, S. Chukwuma, and U. N. Essien, “Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans, ” Journal of Diabetes and Metabolic Disorders, vol. 12, article 60, 2013.
2. P. Vital, E. Larrieta, and M. Hiriart, “Sexual dimorphism in insulin sensitivity ansusceptibility to develop diabetes in rats, ” Journal of Endocrinology, vol. 190, no. 2, pp. 425–432, 2006.
3. M. C. Deeds, J. M. Anderson, A. S. Armstrong et al., “Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models, ” Laboratory Animals, vol. 45, no. 3, pp. 131–140, 2011.
4. B. L. Furman, “Streptozotocin-Induced Diabetic Models in Mice and Rats, ” Current protocols in pharmacology, vol. 70, pp. 5.47.1–5.47.20, 2015.
5. A. Tesfaye, E. Makonnen, and S. Gedamu, “Hypoglycemic and antihyperglycemic activity of aqueous extract of Justicia Schimperiana leaves in normal and streptozotocin-induced diabetic mice, ” International Journal of Pharma Sciences and Research, vol. 7, no. 2, pp. 110–113, 2016.[2] IDF. Diabetes, “Atlas, ” Brussels, Belgium, 2015.
6. A. P. Robertson, “Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes, ” Te Journal of Biological Chemistry, vol. 279, no. 41, pp. 42351–42354, 2004. [25] H. Mulata, N. Gnanasekaran, U. Melaku, and S. Daniel, “Phytochemical screening and assessment of in vitro antioxidant activities of Calpurnia aurea seeds and leaves, ” International Journal of Pharmacy and Pharmaceutical Research, vol. 2, no. 2, pp. 1–12, 2015.
7. S. P. Subramanian and G. S. Prasath, “Antidiabetic and antidyslipidemic nature of trigonelline, a major alkaloid of fenugreek seeds studied in high-fat-fed and low-dose streptozotocin induced experimental diabetic rats, ” Biomedicine and Preventive Nutrition, vol. 4, no. 4, pp. 475–480, 2014.
8. Hu FB. Globalization of Diabetes the role of diet, lifestyle, and genes. Diabetes Care 2011; 34:1249-57.
9. IDF diabetes atlas, fi fth edition. Available form: http://www.idf.org/ diabetesatlas/5e/the-global-burden [Last accessed on 2013 Apr 20].
10. Parasuraman S, Kumar E, Kumar A, Emerson S. Free radical scavenging property and diuretic effect of triglize, a polyherbal formulation in experimental models. J Pharmacol Pharmacother 2010; 1:38-41.
11. Catherine T. The Role of Ayurvedic Therapies for HIV/AIDS Care: A comprehensive review of the literature. J Glob Health Perspect Available from: http://jglobalhealth.org/article/the-role-of-ayurvedic-therapiesfor-hivaids-care- a-comprehensive-review-of-the -literature-2/. [Last accessed on 2013 Jan 05].
12. Kokate CK, Kokate CK. Practical Pharmacognosy. 4th ed. 1994: Vallabh Publications/Prakashan.
13. Rabbani SI, Devi K, Khanam S. Protective role of glibenclamide against nicotinamide-streptozotocin induced nuclear damage in diabetic Wistar rats. J Pharmacol Pharmacother 20101; 1:18-23.
14. Alenzi FQ. Effect of nicotinamide on experimental induced diabetes. Iran J Allergy Asthma Immunol 2009; 8:11-8.
15. Graham ML, Janecek JL, Kittredge JA, Hering BJ, Schuurman HJ. The streptozotocin-induced diabetic nude mouse model: Differences between animals from different sources. Comp Med 2011; 61:356-60.
16. Hakkim FL, Girija S, Kumar RS, Jalaluddeen MD. Effect of aqueous and ethanol extracts of Cassia auriculata L. fl owers on diabetes using alloxan induced diabetic rats. Int J Diabetes Metab 2007; 15:100-6.